Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698354 | Clinical Oncology | 2015 | 9 Pages |
Abstract
The pretreatment albumin level was a significant prognostic indicator for survival. Similarly, the primary cancer site, KPS and number of visceral metastases were associated with survival; these findings were consistent with the results of previous studies. The pretreatment analgesic use was significant using the univariate and multivariate analyses and this factor can be verified in future trials. Self-reported pain intensity, pain response to radiotherapy and MRI findings did not influence survival times.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M.D. Switlyk, U. Kongsgaard, S. Skjeldal, J.K. Hald, K.H. Hole, K. Knutstad, O. Zaikova,